The bill seeks to improve health care provisions in Minnesota by amending various statutes related to prescription drug prior authorizations, price transparency, and health maintenance organizations (HMOs). Key provisions include the requirement for electronic submission of prescription drug prior authorization requests using the NCPDP SCRIPT Standard starting January 1, 2027, and the introduction of new reporting requirements for drug manufacturers, pharmacies, and pharmacy benefit managers (PBMs) regarding drug pricing and market entry of generics. The bill also enhances transparency by mandating that marketing materials from HMOs clearly disclose coverage limitations and that they maintain an accurate provider directory, which must be updated monthly and provided in hard copy upon request.

Additionally, the legislation addresses consumer protection by ensuring coverage for preventive services without cost-sharing and prohibiting prior authorization for certain emergency and outpatient services. It streamlines data access between state agencies and the University of Minnesota, allowing for better data sharing while ensuring compliance with privacy laws. The bill also repeals outdated provisions related to the Health Technology Advisory Committee, transferring decision-making authority for health care provider spending commitments to the commissioner of health. Overall, these amendments aim to enhance transparency, improve consumer access to information, and simplify regulatory processes in Minnesota's health care system.

Statutes affected:
Introduction: 62J.497, 62J.536, 13.7191, 60D.15, 60D.21, 60D.23, 62D.02, 62D.08, 62D.09, 62D.124, 62D.221, 62K.02, 62K.03, 62K.075, 62K.105, 62K.14, 62M.07, 62Q.46, 62U.04, 62W.06, 62J.17, 62J.2930, 144.293